Hypoxia is a key factor in the pathogenesis of gliomas, which enhances tumor development by increasing the expression of stemness (CD133, SOX-2) and drug resistance markers (TIMP-1, Lamp-1) in tumor cells [218]. This evidence concerns the gene TIMP1 and neoplasm.